Clinical Trial Update: Sedation Depth in Neurocritical Care [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the depth of sedation in neurocritical care patients with cerebrovascular disease requiring ventilation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Stroke

Snippet

Sponsor: Heidelberg University | Conditions: Sedation of Cerebrovascular Ventilated Critical Care Patients | Phase 2 | Status: UNKNOWN